Navigation Links
Molecular Vision and Acrongenomics Unable to Reach Agreement on the Acquisition of Molecular Vision
Date:4/8/2008

LONDON, April 8 /PRNewswire/ -- The Board of Molecular Vision today announces that discussions with Acrongenomics on the proposed acquisition of Molecular Vision have now ceased. Acrongenomics has been unable to complete on the terms and timetable agreed. Given this, the Board of Molecular Vision believes that the best interests of the company are served by bringing these discussions to a conclusion. Acrongenomics remains a significant shareholder in Molecular Vision, having recently acquired a 10.9% stake in the company, and work continues on the joint development agreement between the two companies that commenced in March 2006.

About Molecular Vision Limited

Molecular Vision is developing low cost easy-to-use credit-card sized devices for medical testing that will greatly extend the in-house tools available to the general practitioner. The devices are being developed to allow near patient quantitative diagnosis, currently focusing on key areas of high disease burden, namely kidney function and cardiovascular disease. The technology also has additional applications outside the diagnostics market (e.g. forensic science, homeland security and environmental monitoring).

For more information contact:

Molecular Vision

Dr. Ian Campbell

CEO

+44-207-594-1430


'/>"/>
SOURCE Molecular Vision Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
2. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
3. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
4. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
5. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
6. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
7. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Astex Drug Candidates to be Featured at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9. Center for Molecular Medicine One of the First Midwest Labs to Offer Advanced Test for Patients with Metastatic Breast Cancer
10. Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007
11. Center for Molecular Medicine Offers Xceed Ziplex(TM) Services to Research Community

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...Nov. 20 Cell Therapeutic...ay that the Ninth Circuit Court of Appeals reverse...hould be allowed to pursue all of its claims again...strict Court for trial. CTI filed a complaint aga...bursement consultant for CTI,s product TRISENOX, i...
(Date:11/19/2009)... 19 Omeros Corporation (...l results for the third quarter ended September 30...009, Omeros reported a net loss of $3.9 million, o....4 million, or $2.54 per share, for the same perio... 2009, the Company reported a net loss of $15.5 mi...
(Date:11/19/2009)...Pa. and WALTHAM, Mass., Nov. 19 Ar...rces find that the leading driver of antibiotic se...-spectrum activity against gram-positive and gram-...s that can cause nosocomial pneumonia, surveyed Eu...for agents that provide appropriate coverage again...
(Date:11/19/2009)... InSound is honored by latest award for revolutio...k, CA (PRWEB) November 16, 2009 -- Popular Science...uo; hearing aid from InSound Medical a winner of i...ealth category.    Chosen from...e deep in the hearing canal for up to four months ...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
...ison, Wis. - Are state government information tec...ve, problematic, and time-consuming? , ,Matt Misze...cated the problems Wisconsin is having with IT con...s. He has plenty of support on that point, especia...uns, implementation delays, and outright failures ...
...ison, Wis. - GenTel BioSciences, Inc., a develo...1.2 million Phase II SBIR grant from the National ...es less painful diagnosis of respiratory allergies... mild to chronic seasonal allergies, and current d...children and senior citizens. GenTel,s protein chi...
...consin Rapids, Wis. - Cyber Defense Agency , a W...earch company, is warning that widespread use of o... military and other organizations could expose the...tacks buried deep within the millions of lines of ...ices for the U.S. government and various infrastru...
Other Biology Technology:State IT failures are not inevitable 2State IT failures are not inevitable 3State IT failures are not inevitable 4State IT failures are not inevitable 5GenTel gets federal grant to develop allergy test 2GenTel gets federal grant to develop allergy test 3Company issues warning on outsourced software 2Company issues warning on outsourced software 3
(Date:11/20/2009)...s., November 19, 2009 The estimated 4.6 million A... risk of developing respiratory symptoms due to po...tionnaire study undertaken earlier this year by in...of Veterinary Medicine. , The studywhich polled ...hat 50 percent of individuals working in barns com...
(Date:11/20/2009)...ion of a single bacterial gene into yeast, researc...therlands achieved three improvements in bioethano...re ethanol, less acetate and elimination of the ma...as published in the scientific journal Applied an...Bioethanol is made by the yeast Saccharomyces cere...
(Date:11/20/2009)...vailable in German . , In the current onlin..., Dr. Stefanie Eyerich and Dr. Kilian Eyerich toge...ondon and Istituto Dermopatico dell,Immacolata in ...epresents a milestone on the way to developing new...such as psoriasis and allergic reactions and poten...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Delft breakthrough in bioethanol production from agricultural waste 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2First Midwest Healthcare Business Intelligence 28BI 29 Summit October 27 in Minneapolis 3B International Panel to Discuss New Regulations Recession 53320 1First Midwest Healthcare Business Intelligence 28BI 29 Summit October 27 in Minneapolis 3B International Panel to Discuss New Regulations Recession 53320 2First Midwest Healthcare Business Intelligence 28BI 29 Summit October 27 in Minneapolis 3B International Panel to Discuss New Regulations Recession 53320 3First Midwest Healthcare Business Intelligence 28BI 29 Summit October 27 in Minneapolis 3B International Panel to Discuss New Regulations Recession 53320 4Dignitaries Come Together to Honor Participants in the Team Sarcoma Initiative 53318 1Dignitaries Come Together to Honor Participants in the Team Sarcoma Initiative 53318 2Dignitaries Come Together to Honor Participants in the Team Sarcoma Initiative 53318 3Dignitaries Come Together to Honor Participants in the Team Sarcoma Initiative 53318 4Natural Healers Launches 26quot 3BWellness Community Bulletin 26quot 3B 53316 1Natural Healers Launches 26quot 3BWellness Community Bulletin 26quot 3B 53316 2Natural Healers Launches 26quot 3BWellness Community Bulletin 26quot 3B 53316 3Natural Healers Launches 26quot 3BWellness Community Bulletin 26quot 3B 53316 4
... at least since the days of Bob Dylan. But now th... Michael E. Wysession, Ph.D., associate pro...ciences at Washington University in St. Louis, has... format in February. Its a sort of brainiac,s box...ct of the Earth, from its origins and composition ...
...ausing genes will be much easier and faster using ...researchers at The University of Texas at Austin. ... researcher Insuk Lee, used the gene network techn... and are involved in tumor development in the nema...s group at The Wellcome Trust Sanger Institute, th...
...sons to investigate the link between nutrition and...y will look at which nutrients are most important ...om three young offenders institutions housing male...plements on top of their normal choice of food to ...ls and essential fatty acids to meet daily guideli...
Other Biology News:Professor's video series explains all facets of Earth 2Gene discovery made easier with powerful new networking technique 2Prison study to investigate link between diet and behavior 2
Rabbit Anti-HALOPERIDOL Polyclonal Antibody, Unconjugated from AbD Serotec
Mouse Serpin A1 from R&D Systems
Rabbit Anti-SALMONELLA (GROUP ANTIGEN) Polyclonal Antibody, HRP Conjugated from AbD Serotec
beta-galactosidase Colorimetric Assay Kit from Cell Signaling Technology
Biology Products: